Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization

JM M. Friedman, Shelin Adam, Laura Arbour, Linlea Armstrong, Agnes Baross, Patricia Birch, Cornelius Boerkoel, Susanna Chan, David Chai, Allen D. Delaney, Stephane Flibotte, William T. Gibson, Sylvie Langlois, Emmanuelle Lemyre, H. Irene Li, Patrick MacLeod, Joan Mathers, Jacques L. Michaud, Barbara C. McGillivray, Millan S. PatelHong Qian, Guy A. Rouleau, Margot I. Van Allen, Siu Li Yong, Farah R. Zahir, Patrice Eydoux, Marco A. Marra

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Array genomic hybridization is being used clinically to detect pathogenic copy number variants in children with intellectual disability and other birth defects. However, there is no agreement regarding the kind of array, the distribution of probes across the genome, or the resolution that is most appropriate for clinical use. Results: We performed 500 K Affymetrix GeneChip® array genomic hybridization in 100 idiopathic intellectual disability trios, each comprised of a child with intellectual disability of unknown cause and both unaffected parents. We found pathogenic genomic imbalance in 16 of these 100 individuals with idiopathic intellectual disability. In comparison, we had found pathogenic genomic imbalance in 11 of 100 children with idiopathic intellectual disability in a previous cohort who had been studied by 100 K GeneChip® array genomic hybridization. Among 54 intellectual disability trios selected from the previous cohort who were re-tested with 500 K GeneChip® array genomic hybridization, we identified all 10 previously-detected pathogenic genomic alterations and at least one additional pathogenic copy number variant that had not been detected with 100 K GeneChip® array genomic hybridization. Many benign copy number variants, including one that was de novo, were also detected with 500 K array genomic hybridization, but it was possible to distinguish the benign and pathogenic copy number variants with confidence in all but 3 (1.9%) of the 154 intellectual disability trios studied. Conclusion: Affymetrix GeneChip® 500 K array genomic hybridization detected pathogenic genomic imbalance in 10 of 10 patients with idiopathic developmental disability in whom 100 K GeneChip® array genomic hybridization had found genomic imbalance, 1 of 44 patients in whom 100 K GeneChip® array genomic hybridization had found no abnormality, and 16 of 100 patients who had not previously been tested. Effective clinical interpretation of these studies requires considerable skill and experience.

Original languageEnglish
Article number526
JournalBMC Genomics
Volume10
DOIs
Publication statusPublished - 16 Nov 2009
Externally publishedYes

Fingerprint

Nucleic Acid Hybridization
Intellectual Disability
Single Nucleotide Polymorphism
Disabled Children
Developmental Disabilities
Parents
Genome

ASJC Scopus subject areas

  • Biotechnology
  • Genetics

Cite this

Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. / Friedman, JM M.; Adam, Shelin; Arbour, Laura; Armstrong, Linlea; Baross, Agnes; Birch, Patricia; Boerkoel, Cornelius; Chan, Susanna; Chai, David; Delaney, Allen D.; Flibotte, Stephane; Gibson, William T.; Langlois, Sylvie; Lemyre, Emmanuelle; Li, H. Irene; MacLeod, Patrick; Mathers, Joan; Michaud, Jacques L.; McGillivray, Barbara C.; Patel, Millan S.; Qian, Hong; Rouleau, Guy A.; Van Allen, Margot I.; Yong, Siu Li; Zahir, Farah R.; Eydoux, Patrice; Marra, Marco A.

In: BMC Genomics, Vol. 10, 526, 16.11.2009.

Research output: Contribution to journalArticle

Friedman, JMM, Adam, S, Arbour, L, Armstrong, L, Baross, A, Birch, P, Boerkoel, C, Chan, S, Chai, D, Delaney, AD, Flibotte, S, Gibson, WT, Langlois, S, Lemyre, E, Li, HI, MacLeod, P, Mathers, J, Michaud, JL, McGillivray, BC, Patel, MS, Qian, H, Rouleau, GA, Van Allen, MI, Yong, SL, Zahir, FR, Eydoux, P & Marra, MA 2009, 'Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization', BMC Genomics, vol. 10, 526. https://doi.org/10.1186/1471-2164-10-526
Friedman, JM M. ; Adam, Shelin ; Arbour, Laura ; Armstrong, Linlea ; Baross, Agnes ; Birch, Patricia ; Boerkoel, Cornelius ; Chan, Susanna ; Chai, David ; Delaney, Allen D. ; Flibotte, Stephane ; Gibson, William T. ; Langlois, Sylvie ; Lemyre, Emmanuelle ; Li, H. Irene ; MacLeod, Patrick ; Mathers, Joan ; Michaud, Jacques L. ; McGillivray, Barbara C. ; Patel, Millan S. ; Qian, Hong ; Rouleau, Guy A. ; Van Allen, Margot I. ; Yong, Siu Li ; Zahir, Farah R. ; Eydoux, Patrice ; Marra, Marco A. / Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization. In: BMC Genomics. 2009 ; Vol. 10.
@article{e4cdb55000aa4f1ab8cb0c002ba76adc,
title = "Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization",
abstract = "Background: Array genomic hybridization is being used clinically to detect pathogenic copy number variants in children with intellectual disability and other birth defects. However, there is no agreement regarding the kind of array, the distribution of probes across the genome, or the resolution that is most appropriate for clinical use. Results: We performed 500 K Affymetrix GeneChip{\circledR} array genomic hybridization in 100 idiopathic intellectual disability trios, each comprised of a child with intellectual disability of unknown cause and both unaffected parents. We found pathogenic genomic imbalance in 16 of these 100 individuals with idiopathic intellectual disability. In comparison, we had found pathogenic genomic imbalance in 11 of 100 children with idiopathic intellectual disability in a previous cohort who had been studied by 100 K GeneChip{\circledR} array genomic hybridization. Among 54 intellectual disability trios selected from the previous cohort who were re-tested with 500 K GeneChip{\circledR} array genomic hybridization, we identified all 10 previously-detected pathogenic genomic alterations and at least one additional pathogenic copy number variant that had not been detected with 100 K GeneChip{\circledR} array genomic hybridization. Many benign copy number variants, including one that was de novo, were also detected with 500 K array genomic hybridization, but it was possible to distinguish the benign and pathogenic copy number variants with confidence in all but 3 (1.9{\%}) of the 154 intellectual disability trios studied. Conclusion: Affymetrix GeneChip{\circledR} 500 K array genomic hybridization detected pathogenic genomic imbalance in 10 of 10 patients with idiopathic developmental disability in whom 100 K GeneChip{\circledR} array genomic hybridization had found genomic imbalance, 1 of 44 patients in whom 100 K GeneChip{\circledR} array genomic hybridization had found no abnormality, and 16 of 100 patients who had not previously been tested. Effective clinical interpretation of these studies requires considerable skill and experience.",
author = "Friedman, {JM M.} and Shelin Adam and Laura Arbour and Linlea Armstrong and Agnes Baross and Patricia Birch and Cornelius Boerkoel and Susanna Chan and David Chai and Delaney, {Allen D.} and Stephane Flibotte and Gibson, {William T.} and Sylvie Langlois and Emmanuelle Lemyre and Li, {H. Irene} and Patrick MacLeod and Joan Mathers and Michaud, {Jacques L.} and McGillivray, {Barbara C.} and Patel, {Millan S.} and Hong Qian and Rouleau, {Guy A.} and {Van Allen}, {Margot I.} and Yong, {Siu Li} and Zahir, {Farah R.} and Patrice Eydoux and Marra, {Marco A.}",
year = "2009",
month = "11",
day = "16",
doi = "10.1186/1471-2164-10-526",
language = "English",
volume = "10",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Detection of pathogenic copy number variants in children with idiopathic intellectual disability using 500 K SNP array genomic hybridization

AU - Friedman, JM M.

AU - Adam, Shelin

AU - Arbour, Laura

AU - Armstrong, Linlea

AU - Baross, Agnes

AU - Birch, Patricia

AU - Boerkoel, Cornelius

AU - Chan, Susanna

AU - Chai, David

AU - Delaney, Allen D.

AU - Flibotte, Stephane

AU - Gibson, William T.

AU - Langlois, Sylvie

AU - Lemyre, Emmanuelle

AU - Li, H. Irene

AU - MacLeod, Patrick

AU - Mathers, Joan

AU - Michaud, Jacques L.

AU - McGillivray, Barbara C.

AU - Patel, Millan S.

AU - Qian, Hong

AU - Rouleau, Guy A.

AU - Van Allen, Margot I.

AU - Yong, Siu Li

AU - Zahir, Farah R.

AU - Eydoux, Patrice

AU - Marra, Marco A.

PY - 2009/11/16

Y1 - 2009/11/16

N2 - Background: Array genomic hybridization is being used clinically to detect pathogenic copy number variants in children with intellectual disability and other birth defects. However, there is no agreement regarding the kind of array, the distribution of probes across the genome, or the resolution that is most appropriate for clinical use. Results: We performed 500 K Affymetrix GeneChip® array genomic hybridization in 100 idiopathic intellectual disability trios, each comprised of a child with intellectual disability of unknown cause and both unaffected parents. We found pathogenic genomic imbalance in 16 of these 100 individuals with idiopathic intellectual disability. In comparison, we had found pathogenic genomic imbalance in 11 of 100 children with idiopathic intellectual disability in a previous cohort who had been studied by 100 K GeneChip® array genomic hybridization. Among 54 intellectual disability trios selected from the previous cohort who were re-tested with 500 K GeneChip® array genomic hybridization, we identified all 10 previously-detected pathogenic genomic alterations and at least one additional pathogenic copy number variant that had not been detected with 100 K GeneChip® array genomic hybridization. Many benign copy number variants, including one that was de novo, were also detected with 500 K array genomic hybridization, but it was possible to distinguish the benign and pathogenic copy number variants with confidence in all but 3 (1.9%) of the 154 intellectual disability trios studied. Conclusion: Affymetrix GeneChip® 500 K array genomic hybridization detected pathogenic genomic imbalance in 10 of 10 patients with idiopathic developmental disability in whom 100 K GeneChip® array genomic hybridization had found genomic imbalance, 1 of 44 patients in whom 100 K GeneChip® array genomic hybridization had found no abnormality, and 16 of 100 patients who had not previously been tested. Effective clinical interpretation of these studies requires considerable skill and experience.

AB - Background: Array genomic hybridization is being used clinically to detect pathogenic copy number variants in children with intellectual disability and other birth defects. However, there is no agreement regarding the kind of array, the distribution of probes across the genome, or the resolution that is most appropriate for clinical use. Results: We performed 500 K Affymetrix GeneChip® array genomic hybridization in 100 idiopathic intellectual disability trios, each comprised of a child with intellectual disability of unknown cause and both unaffected parents. We found pathogenic genomic imbalance in 16 of these 100 individuals with idiopathic intellectual disability. In comparison, we had found pathogenic genomic imbalance in 11 of 100 children with idiopathic intellectual disability in a previous cohort who had been studied by 100 K GeneChip® array genomic hybridization. Among 54 intellectual disability trios selected from the previous cohort who were re-tested with 500 K GeneChip® array genomic hybridization, we identified all 10 previously-detected pathogenic genomic alterations and at least one additional pathogenic copy number variant that had not been detected with 100 K GeneChip® array genomic hybridization. Many benign copy number variants, including one that was de novo, were also detected with 500 K array genomic hybridization, but it was possible to distinguish the benign and pathogenic copy number variants with confidence in all but 3 (1.9%) of the 154 intellectual disability trios studied. Conclusion: Affymetrix GeneChip® 500 K array genomic hybridization detected pathogenic genomic imbalance in 10 of 10 patients with idiopathic developmental disability in whom 100 K GeneChip® array genomic hybridization had found genomic imbalance, 1 of 44 patients in whom 100 K GeneChip® array genomic hybridization had found no abnormality, and 16 of 100 patients who had not previously been tested. Effective clinical interpretation of these studies requires considerable skill and experience.

UR - http://www.scopus.com/inward/record.url?scp=71049129029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71049129029&partnerID=8YFLogxK

U2 - 10.1186/1471-2164-10-526

DO - 10.1186/1471-2164-10-526

M3 - Article

C2 - 19917086

AN - SCOPUS:71049129029

VL - 10

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

M1 - 526

ER -